Skip to main content
Jane Schwebke, MD, Infectious Disease, Birmingham, AL, Birmingham VA Medical Center

JaneRSchwebkeMD

Infectious Disease • Birmingham, AL

Professor, Medicine, University of Alabama School of Medicine

Join to view full profile

Dr. Schwebke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schwebke's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Infectious Disease, 1988 - 1989
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1984 - 1987
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1984

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1985 - 2026
  • AL State Medical License
    AL State Medical License 1994 - 2024
  • FL State Medical License
    FL State Medical License 2012 - 2016
  • WA State Medical License
    WA State Medical License 1987 - 1991
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Safety and Efficacy of a Novel Vaginal Anti-Infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-Blind, Phase...  
    Jeanne M Marrazzo, Julia C Dombrowski, Angela Pontius, Dwyn Dithmer, Jane Schwebke, Clinical Infectious Diseases

Press Mentions

  • Engineered Phage Endolysin Is a Potential Solution for Recurrent Bacterial Vaginosis
    Engineered Phage Endolysin Is a Potential Solution for Recurrent Bacterial VaginosisOctober 28th, 2020
  • SCYNEXIS Announces Presentations at 2020 IDSOG Virtual Annual Meeting Highlighting Ibrexafungerp’s Potential for the Treatment of Vulvovaginal Candidiasis
    SCYNEXIS Announces Presentations at 2020 IDSOG Virtual Annual Meeting Highlighting Ibrexafungerp’s Potential for the Treatment of Vulvovaginal CandidiasisAugust 13th, 2020
  • Newly Published Research Shows That Hologic’s Molecular Assays for Diagnosing Vaginitis Are More Effective Than Traditional Methods
    Newly Published Research Shows That Hologic’s Molecular Assays for Diagnosing Vaginitis Are More Effective Than Traditional MethodsNovember 25th, 2019
  • Join now to see all

Grant Support

  • The UAB Infectious Diseases Training GrantNational Institute Of Allergy And Infectious Diseases2008–2011
  • UAB Infectious Diseases Training GrantNational Institute Of Allergy And Infectious Diseases2005–2007
  • Tinidazole For The Treatment Of Bacterial VaginosisNational Institute Of Allergy And Infectious Diseases2004–2007
  • Therapy And Prevention For Bacterial VaginosisNational Institute Of Allergy And Infectious Diseases2002–2006
  • Control Of Trichomoniasis -A Paradigm For STD ControlNational Institute Of Allergy And Infectious Diseases2002–2006
  • Concordance Rates Of Mobiluncus Among Sexual PartnersEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2004
  • Bacterial Vaginosis--Pathogenesis And Impact On Sexually Transmitted DiseasesNational Institute Of Allergy And Infectious Diseases1995–2002
  • Lower Genital Tract Infection In A Rural PopulationEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–2000

Hospital Affiliations

Dr. Jane Schwebke, Dr. Jane Schwebke, MD, Dr. J Schwebke, Dr. Jane R Schwebke